Delivery Order SPE2DP20D0002-SPE2DP24F3361
- Not listed
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $476,414.19 award is for the supply of Adenovirus Type 4, a vaccine, with a completion date of January 30, 2024. This contract is not set aside for any specific business designation. Teva Pharmaceuticals USA, Inc. is a subsidiary of Teva Pharmaceutical Industries Ltd., a leading global...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $158,804.73 contract, which has no set-aside designation, is for the supply of Adenovirus Type 4 A vaccine with a completion date of February 27, 2024. Teva Pharmaceuticals USA, Inc. has been awarded multiple federal contracts and delivery orders from agencies like the Department of Veterans...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $476,414.19 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The contract has a completion date of February 27, 2024 and does not utilize a set-aside designation. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva Pharmaceutical Industries Ltd. and has been awarded numerous prime...
- This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency's Troop Support Medical division to Teva Pharmaceuticals USA, Inc., a foreign-owned pharmaceutical manufacturer, for the delivery of Adenovirus Type 4 vaccine. The $317,609.46 contract has an ultimate completion date of December 3, 2024 and is not set aside for any particular business type. Teva Pharmaceuticals is a major supplier of critical medical products, including vaccines, to various federal...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $476,414.19 firm fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccines. This contract, which has a completion date of May 21, 2024, supports military immunization programs. Teva Pharmaceuticals USA, Inc. has a long history of supplying critical pharmaceuticals, including other vaccines and medications, to various federal...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $317,609.46 firm fixed-price delivery order is for the supply of Adenovirus Type 4 vaccines, supporting military immunization programs. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global Teva Pharmaceutical Industries Ltd. and has numerous prime contract awards with federal agencies, including...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $635,218.92 order is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. The order has a completion date of February 27, 2024 and was awarded on February 22, 2024. This award is not associated with a set-aside designation. Teva Pharmaceuticals USA,...
- This is a delivery order awarded to Teva Pharmaceuticals USA, Inc. by the Defense Logistics Agency Troop Support Medical, with a completion date of April 27, 2021. The order is for $282,353.76 to provide Adenovirus Type 4 vaccine, under a firm-fixed-price contract. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit manufacturer of pharmaceutical products, including vaccines, antivirals, and respiratory treatments, that has supplied the U.S. government, including the Department of...
- The Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit manufacturer, to provide Adenovirus Type 4 vaccine. The $135,747.00 award has an October 27, 2020 completion date and was issued on October 19, 2020. This delivery order supports military immunization programs. Teva Pharmaceuticals USA, Inc. holds multiple indefinite delivery contracts with federal agencies, including a 5-year IDIQ with the...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to supply Adenovirus Type 4 vaccine. The $282,353.76 contract has a completion date of January 26, 2021. Teva Pharmaceuticals is a foreign-owned, for-profit organization that provides a range of drug products to federal agencies, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs. The...
- SPE2DP20D0002Indefinite Delivery Contract
- SPE2DP20D0002-SPE2DP24F3361Delivery Order
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $317,609.46 award is to provide Adenovirus Type 4 vaccine, with an ultimate completion date of March 26, 2024. Teva Pharmaceuticals USA is an experienced federal contractor, having been awarded numerous prime contracts and delivery orders by agencies such as the Department of Veterans Affairs (VA), Department of Defense (DOD), and the Bureau of Prisons to supply critical pharmaceuticals including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs. This delivery order was not set aside for any specific business designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $317.6k | 3/19/24 |